Immunoglobulin purification

Patent metadata

Field	Value
Publication number	US-9493548-B2
Application number	US-59970308-A
Country	US
Kind code	B2
Filing date	May 28, 2008
Priority date	Jun 1, 2007
Publication date	Nov 15, 2016
Grant date	Nov 15, 2016

Abstract

The current invention reports a method for purifying an immunoglobulin, wherein the method comprises applying an aqueous, buffered solution comprising an immunoglobulin in monomeric and in aggregated form to a cation exchange material under conditions whereby the immunoglobulin in monomeric form does not bind to the cation exchange material, and recovering the immunoglobulin in monomeric form from the solution after the contact with the cation exchange material.

First claim

The invention claimed is:

1. A method for obtaining an immunoglobulin in monomeric form from a solution comprising the immunoglobulin in monomeric and in aggregated form, comprising the steps of:
a) applying an aqueous, buffered solution comprising said immunoglobulin in monomeric and in aggregated form to a cation exchange membrane under conditions whereby at least 90% of said immunoglobulin in monomeric form does not bind to said cation exchange membrane, and
b) recovering said immunoglublin in monomeric form from said aqueous, buffered solution after the contact with said cation exchange membrane,

wherein said step a) is a chromatography step operated in flow-through mode and said aqueous, buffered solution has a pH value of from pH 5 to pH 8 and said aqueous, buffered solution of step a) has a conductivity of from 4.0 to 10.0 mS/cm and the sum of pH value and conductivity in mS/cm of the aqueous, buffered solution in step a) is in the range of from 10 to 15.

2. The method according to claim 1 , wherein said cation exchange membrane is a polyethersulfone based membrane or a regenerated cellulose based membrane modified with sulfonic acid groups or carboxymethyl groups.

3. The method according to claim 1 , wherein said recovering said immunoglobulin in monomeric form from the flow-through is by a method selected from precipitation, salting out, ultrafiltration, diafiltration, lyophilization, affinity chromatography, or solvent volume reduction to obtain a concentrated solution.

4. The method according to claim 1 , wherein said recovering is by ultrafiltration, lyophilization, or solvent volume reduction.

5. The method according to claim 1 , whereby at least 95% of said immunoglobulin in monomeric form does not bind to said cation exchange membrane.

6. The method according to claim 1 , wherein said aqueous, buffered solution is a solution comprising phosphoric acid or salts thereof, citric acid or salts thereof, or histidine or salts thereof.

7. The method according to claim 1 , wherein said aqueous, buffered solution comprises sodium chloride or potassium chloride.

8. The method according to claim 1 , wherein said chromatography step is a column chromatography or a cassette chromatography.

Assignees

• Falkenstein Roberto
• Giessel Claudia
• Hoffmann La Roche

Inventors

• Falkenstein Roberto
• Giessel Claudia

Classifications

• C07K16/244

  Interleukins [IL] · CPC title

• C07K16/32

  against translation products of oncogenes · CPC title

• C07K16/065 Primary

  Purification, fragmentation · CPC title

• C07K1/16

  by chromatography · CPC title

• C07K1/18 Primary

  Ion-exchange chromatography · CPC title